January 1985
Volume 26, Issue 1
Articles  |   January 1985
Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas.
Investigative Ophthalmology & Visual Science January 1985, Vol.26, 105-110. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J R Brightwell, S L Riddle, R A Eiferman, P Valenzuela, P J Barr, J P Merryweather, G S Schultz; Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas.. Invest. Ophthalmol. Vis. Sci. 1985;26(1):105-110.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Topical administration of biosynthetic human epidermal growth factor (h-EGF), given in combination with an antibiotic and synthetic steroid (Neodecadron) accelerated the rate of corneal epithelial regeneration and significantly increased the strength of full-thickness stromal incisions in primates. The regenerated epithelial cells of EGF-Neodecadron-treated corneas appeared normal on histologic examination and showed no evidence of hypertrophy or hyperplasia. The EGF-Neodecadron-treated stromal incisions were characterized by new collagen formation and a smaller epithelial cell plug than Neodecadron-treated control corneas. These results suggest that biosynthetic h-EGF, which lacks the immunologic potential of nonhuman proteins, may be effective in accelerating healing of corneal epithelial defects and stromal incisions in patients whose healing is suppressed by treatment with steroids.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.